Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU patients
Copyright © 2021 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved..
BACKGROUND: Hospitalized COVID-19 patients are prone to develop persistent symptoms and to show reduced quality of life following hospital admission.
METHODS: Prospective cohort study of COVID-19 patients admitted to a hospital from March 1 to April 30, 2020. The primary outcome was to compare health related quality of life and persistent symptoms six months after hospital admission, of COVID-19 patients who required ICU admission with those who did not.
RESULTS: Among the 242 patients hospitalized during the defined period of time, 44 (18.2%) needed ICU admission. Forty (16.5%) patients died during hospital admission. Two hundred and two (83.5%) patients were discharged alive from the hospital. At six months, 183 (75.6%) patients completed the questionnaires (32 ICU patients and 151 non ICU patients). Ninety-six (52.4%) reported decreased quality of life and 143 (78.1%) described persistent symptoms. More ICU patients showed worsening of their quality of life (71.9% vs 43.7%, P=0.004). There were no differences in the proportion of patients with persistent symptoms between ICU and non ICU patients (87.5% vs 76.2%, P=0.159). ICU patients showed more frequently dyspnea on exertion (78.1% vs 47.7%, P=0.02), dyspnea on light exertion (37.5% vs 4.6%, P<0.001), and asthenia (56.3 vs 29.1, P=0.003).
CONCLUSIONS: Survivors of COVID-19 needing hospitalization had persistent symptoms and a decline in the quality of life. ICU patients referred a large decrease of their quality of life compared with non ICU patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Revista espanola de anestesiologia y reanimacion - 69(2022), 6 vom: 15. Juni, Seite 326-335 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Taboada, M [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.07.2022 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.redare.2022.06.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342816667 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342816667 | ||
| 003 | DE-627 | ||
| 005 | 20231226015005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.redare.2022.06.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342816667 | ||
| 035 | |a (NLM)35760688 | ||
| 035 | |a (PII)S2341-1929(22)00090-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Taboada, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.07.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a BACKGROUND: Hospitalized COVID-19 patients are prone to develop persistent symptoms and to show reduced quality of life following hospital admission | ||
| 520 | |a METHODS: Prospective cohort study of COVID-19 patients admitted to a hospital from March 1 to April 30, 2020. The primary outcome was to compare health related quality of life and persistent symptoms six months after hospital admission, of COVID-19 patients who required ICU admission with those who did not | ||
| 520 | |a RESULTS: Among the 242 patients hospitalized during the defined period of time, 44 (18.2%) needed ICU admission. Forty (16.5%) patients died during hospital admission. Two hundred and two (83.5%) patients were discharged alive from the hospital. At six months, 183 (75.6%) patients completed the questionnaires (32 ICU patients and 151 non ICU patients). Ninety-six (52.4%) reported decreased quality of life and 143 (78.1%) described persistent symptoms. More ICU patients showed worsening of their quality of life (71.9% vs 43.7%, P=0.004). There were no differences in the proportion of patients with persistent symptoms between ICU and non ICU patients (87.5% vs 76.2%, P=0.159). ICU patients showed more frequently dyspnea on exertion (78.1% vs 47.7%, P=0.02), dyspnea on light exertion (37.5% vs 4.6%, P<0.001), and asthenia (56.3 vs 29.1, P=0.003) | ||
| 520 | |a CONCLUSIONS: Survivors of COVID-19 needing hospitalization had persistent symptoms and a decline in the quality of life. ICU patients referred a large decrease of their quality of life compared with non ICU patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Acute respiratorydistress (ARDS) | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Calidad de vidarelacionada con lasalud | |
| 650 | 4 | |a Critically ill patients | |
| 650 | 4 | |a Dificultad respiratoriaaguda (SDRA) | |
| 650 | 4 | |a Estado funcional | |
| 650 | 4 | |a Functional status | |
| 650 | 4 | |a Health-relatedquality of life | |
| 650 | 4 | |a Pacientes críticos | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Rodríguez, N |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz-Vieito, M |e verfasserin |4 aut | |
| 700 | 1 | |a Domínguez, M J |e verfasserin |4 aut | |
| 700 | 1 | |a Casal, A |e verfasserin |4 aut | |
| 700 | 1 | |a Riveiro, V |e verfasserin |4 aut | |
| 700 | 1 | |a Cariñena, A |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno, E |e verfasserin |4 aut | |
| 700 | 1 | |a Pose, A |e verfasserin |4 aut | |
| 700 | 1 | |a Valdés, L |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarez, J |e verfasserin |4 aut | |
| 700 | 1 | |a Seoane-Pillado, T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de anestesiologia y reanimacion |d 2012 |g 69(2022), 6 vom: 15. Juni, Seite 326-335 |w (DE-627)NLM222859482 |x 2341-1929 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2022 |g number:6 |g day:15 |g month:06 |g pages:326-335 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.redare.2022.06.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2022 |e 6 |b 15 |c 06 |h 326-335 | ||